PMID- 7872881 OWN - NLM STAT- MEDLINE DCOM- 19950324 LR - 20190717 IS - 0003-9942 (Print) IS - 0003-9942 (Linking) VI - 52 IP - 3 DP - 1995 Mar TI - Exaggerated messenger RNA expression of inflammatory cytokines in human T-cell lymphotropic virus type I-associated myelopathy. PG - 276-80 AB - OBJECTIVE: To investigate the expression of inflammatory cytokine messenger RNA (mRNA) in peripheral blood mononuclear cells of patients with human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy (HAM). PATIENTS: Seventeen patients with HAM, 18 HTLV-I-seropositive carriers, and 10 seronegative individuals were studied. MAIN OUTCOME MEASURE: We compared the expression of tumor necrosis factor alpha (TNF-alpha), granulocyte-macrophage colony-stimulating factor (GM-CSF), interferon alpha (IFN-alpha), IFN-beta, and IFN-gamma, and interleukin 1 alpha (IL-1 alpha) and IL-1 beta by reverse transcriptase-polymerase chain reaction. RESULTS: In patients with HAM, the reverse transcriptase-polymerase chain reaction products of TNF-alpha, GM-CSF, IFN-gamma, and IL-1 alpha were detected in significantly higher incidences than in HTLV-I-seropositive carriers and seronegative controls. Furthermore, simultaneous mRNA expression of three or more of these four cytokines was detected in all patients with HAM compared with only 21.4% of HTLV-I-seropositive carriers. By contrast, there was no significant difference in mRNA expression of IFN-alpha, IFN-beta, and IL-1 beta among patients with HAM, HTLV-I-seropositive carriers, and HTLV-I-seronegative controls. CONCLUSIONS: An exaggerated mRNA expression of several inflammatory cytokines, including TNF-alpha, GM-CSF, IFN-gamma, and IL-1 alpha, was demonstrated in peripheral blood mononuclear cells of patients with HAM. Moreover, transcripts of these cytokines were simultaneously up-regulated in patients with HAM, suggesting that an inflammatory state in the central nervous system may be related to the pathogenesis of HAM. FAU - Watanabe, H AU - Watanabe H AD - First Department of Internal Medicine, Nagasaki, Japan. FAU - Nakamura, T AU - Nakamura T FAU - Nagasato, K AU - Nagasato K FAU - Shirabe, S AU - Shirabe S FAU - Ohishi, K AU - Ohishi K FAU - Ichinose, K AU - Ichinose K FAU - Nishiura, Y AU - Nishiura Y FAU - Chiyoda, S AU - Chiyoda S FAU - Tsujihata, M AU - Tsujihata M FAU - Nagataki, S AU - Nagataki S LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Arch Neurol JT - Archives of neurology JID - 0372436 RN - 0 (Cytokines) RN - 0 (Interferon-alpha) RN - 0 (Interleukin-1) RN - 0 (RNA, Messenger) RN - 0 (Tumor Necrosis Factor-alpha) RN - 77238-31-4 (Interferon-beta) RN - 82115-62-6 (Interferon-gamma) RN - 83869-56-1 (Granulocyte-Macrophage Colony-Stimulating Factor) SB - IM MH - Adult MH - Aged MH - Base Sequence MH - Cytokines/*genetics MH - Female MH - Granulocyte-Macrophage Colony-Stimulating Factor/genetics MH - Humans MH - Interferon-alpha/genetics MH - Interferon-beta/genetics MH - Interferon-gamma/genetics MH - Interleukin-1/genetics MH - Male MH - Middle Aged MH - Molecular Sequence Data MH - Paraparesis, Tropical Spastic/*genetics MH - RNA, Messenger/*metabolism MH - Tumor Necrosis Factor-alpha/genetics EDAT- 1995/03/01 00:00 MHDA- 1995/03/01 00:01 CRDT- 1995/03/01 00:00 PHST- 1995/03/01 00:00 [pubmed] PHST- 1995/03/01 00:01 [medline] PHST- 1995/03/01 00:00 [entrez] AID - 10.1001/archneur.1995.00540270068021 [doi] PST - ppublish SO - Arch Neurol. 1995 Mar;52(3):276-80. doi: 10.1001/archneur.1995.00540270068021.